This study is being done to examine the effect of Parenteral (intravenous) nutrition support in the home setting on quality of life in cancer patients. In addition, this study is being done to examine the effect of home parenteral nutrition on the use of pain and anti-nausea medication.
This is a prospective descriptive non-randomized clinical study to examine quality of life outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1 year.
Study Type
OBSERVATIONAL
Enrollment
100
Cancer Patients who are discharged on HPN will be monitored for quality of life, nutrition status, pain and nausea medication usage
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Tulsa, Oklahoma, United States
Quality of Life
To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30
Time frame: Monthly for a minimum of 3 months to a maximum of 12 months
Pain and nausea medication usage
To examine the effect of home parenteral nutrition on the use of pain medication and anti-emetic therapy administered intravenously, subcutaneously, or orally.
Time frame: Monthly for a minumum of 3 months to a maximum of 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.